The Nebraska Medicine Stroke Center treats over 700 patients every year.
Below is a table of our 2021 first and second quarter outcomes.
- IV tPA – Intravenous tissue plasminogen activator. This medicine is the only one of its kind to be approved by the Food and Drug Administration for treating an acute ischemic stroke.
- Interventional radiology mechanical thrombectomy – A minimally-invasive surgical procedure done to remove a clot from an artery.
- Groin puncture – Puncturing the skin in the area at the top of your thigh to start an interventional radiology mechanical thrombectomy
- Reperfusion of vessel – Restoring blood flow to an injured area
- Hemorrhagic stroke – A type of stroke caused by a ruptured blood vessel in the brain
|Measure||Nebraska Medicine||Benchmark Goal|
|Percentage of patients treated with IV tPA within 45 min or less||84%||80% of all eligible patients 45 minutes or less|
|Door to interventional radiology mechanical thrombectomy within 45 minutes or less||35 minutes||45 minutes or less|
|Door to groin puncture within 60 minutes or less||42 minutes||60 minutes or less|
|Door to reperfusion of vessel once clot is removed within 120 minutes or less||96 minutes||120 minutes or less|
|Patients who arrive by EMS with stroke signs and symptoms are seen by the stroke team within minutes of arrival||Average of 1 minute||10 minutes or less|
|Hemorrhagic stroke patients who need intervention due to an aneurysm rupture can be treated 24/7 by a Neurovascular Intervention team||34 aneurysm clips or coils in 2020||12 aneurysm clips or coils in the last 12 months|
Goals are based on the requirements outlined to receive recognition and accreditation from the American Heart Association and The Joint Comission Stroke Certification.